Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Postoperative Recovery in AERD and CRS
NCT04147013Phase 4Active, not recruiting
- Start
- Feb 2020
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of celecoxib oral solution in chronic rhinosinusitis with nasal polyps (CRSwNP), Aspirin Exacerbated Respiratory Disease (AERD). Started Feb 2020; status: active, not recruiting.
02
Drugs
celecoxib oral solution
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT04147013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147013.